Alethiomics

About:

Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.

Website: https://www.alethiomics.com

Twitter/X: Alethiomics

Top Investors: Oxford Science Enterprises

Description:

Alethiomics is a pre-clinical biotech company harnessing the power of single-cell multi-omic technology to discover and develop life-changing treatments for patients with blood cancer.

Total Funding Amount:

6M GBP

Headquarters Location:

Headington, Oxfordshire, United Kingdom

Founded Date:

2021-01-01

Contact Email:

hello(AT)alethiomics.com

Founders:

Adam Mead, Bethan Psaila

Number of Employees:

1-10

Last Funding Date:

2021-12-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai